GamaMabs Pharma Competitors and Similar CompaniesClear all
GamaMabs Pharma's competitors and similar companies include Ikena Oncology, Dendreon, Seagen and Mersana Therapeutics.
 Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. |  Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. | ||
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 1992 | Founding Date 1998 | Founding Date 2005 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Toulouse, FR HQ | Locations Boston, US HQ | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 5052% increase | Employees 6131% decrease | Employees 3,25622% increase | Employees 11033% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 82.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 250.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $800k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $40.5m (FY, 2024) |
Net income | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income N/A | Net income ($610.3m) (FY, 2022) | Net income ($69.2m) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 20.5m | Total funding raised $ 49m | Total funding raised N/A | Total funding raised $ 164m | Total funding raised $ 219.5m |
For sources of this data, please see the company profile
View Company Profiles
Ikena Oncology
HQ
Boston, US
Employees
50
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View companyDendreon
HQ
Seal Beach, US
Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
View companySeagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyMersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View company